Tempus AI (NASDAQ:TEM) Stock Price Up 14.9% - Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price was up 14.9% on Thursday . The stock traded as high as $85.71 and last traded at $84.90. Approximately 15,252,055 shares changed hands during mid-day trading, an increase of 18% from the average daily volume of 12,909,801 shares. The stock had previously closed at $73.88.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on TEM shares. TD Cowen reiterated a "buy" rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Bank of America lifted their price target on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a report on Friday, December 13th. Needham & Company LLC reissued a "buy" rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday, January 14th. Loop Capital lowered their price objective on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Finally, William Blair lowered Tempus AI from an "outperform" rating to a "market perform" rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $58.55.

Tempus AI Stock Performance

The company has a fifty day moving average price of $46.60 and a 200-day moving average price of $50.32. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Activity at Tempus AI

In other Tempus AI news, CEO Eric P. Lefkofsky sold 187,655 shares of the company's stock in a transaction on Wednesday, December 18th. The stock was sold at an average price of $37.54, for a total value of $7,044,568.70. Following the transaction, the chief executive officer now owns 9,557,283 shares of the company's stock, valued at $358,780,403.82. This represents a 1.93 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the transaction, the chief accounting officer now directly owns 57,237 shares in the company, valued at $3,434,220. The trade was a 19.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,401,779 shares of company stock worth $115,707,361.

Hedge Funds Weigh In On Tempus AI

Hedge funds and other institutional investors have recently made changes to their positions in the company. First Horizon Advisors Inc. bought a new position in shares of Tempus AI during the 3rd quarter worth $30,000. Operose Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter worth $25,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter worth $34,000. Prestige Wealth Management Group LLC grew its position in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after buying an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter worth $49,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.